2025年全球白血球分離設備市場報告

預計未來幾年白血球分離設備市場將強勁成長，到2029年將達到9.4億美元，複合年成長率為7.5%。預測期內的成長動力包括：血液相關疾病盛行率上升、癌症發生率上升、周邊血幹細胞採集需求成長、白血球分離術（白血球輸血）在細胞治療中的應用不斷擴大，以及再生醫學和免疫治療領域的投資不斷增加。預計這段時期的主要趨勢包括：分離設備的技術創新、自動化與數位技術的融合、床旁白細胞分離系統的進步、閉合迴路分離技術的進步以及細胞分離效率的技術提升。

血液相關疾病的日益普及預計將推動白血球分離設備市場的成長。這些疾病會影響血球的結構和功能，導致氧氣運輸、免疫功能和血液凝固等併發症。導致這一成長的主要原因之一是人口老化，他們更容易患上貧血、白血病和其他血液系統疾病。白血球分離設備在管理這些疾病方面發揮關鍵作用，它透過選擇性地從血液中去除多餘或異常的白血球，從而緩解症狀並降低白血病和自體免疫疾病等疾病併發症的風險。例如，2024年5月，澳洲非營利組織白血病基金會報告稱，2022年約有19,403名澳洲人被診斷出患有血癌，包括白血病、淋巴瘤和骨髓瘤。這相當於每天新增約53例，即每27分鐘新增一例。目前，約有 135,000 名澳洲人正在與血癌和血病作鬥爭，預計到 2035 年將超過 275,000。血液相關疾病的成長趨勢極大地促進了對白血球分離設備的需求不斷成長。

白血球分離設備市場的主要企業正在增加對本地生產能力的投資，以改善治療設備的可及性，並配合國家醫療保健策略。建立本地製造設施有助於簡化供應鏈，減少對進口的依賴，並提高先進血液和細胞採集系統的價格可負擔性和可用性。例如，2024年11月，美國醫療技術公司Terumo Corporation血液與細胞技術公司與其中國子公司Terumo Corporation醫療產品（杭州）有限公司合作，在杭州啟動本地生產。該舉措專注於生產關鍵的白血球分離（白血球輸血）產品，例如Trima Accel自動採血系統和Spectra Optia血液分離系統，這些產品在中國廣泛應用於治療性血液分離、幹細胞採集和血液成分分離等程序。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 全球白血球分離設備：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
• 最終用途產業分析
• 全球白血球分離設備市場：成長率分析
• 全球白血球分離設備市場表現：規模與成長，2019-2024
• 全球白血球分離設備市場預測：規模與成長，2024-2029年，2034年
• 全球白血球分離設備：總目標市場（TAM）

第6章 市場細分

• 全球白血球分離設備市場：按設備類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
• 治療性分離術
• 血球耗竭療法
• 幹細胞採集
• 調查應用
• 白血球分離柱和細胞分離器
• 白血球分離術一次性用品
• 血液分離機
• 全球白血球分離設備市場：按組件、性能和預測，2019-2024 年、2024-2029 年、2034 年
• 白血球分離裝置
• 採血套裝
• 醫療耗材
• 篩選
• 全球白血球分離設備市場：按最終用戶、實際和預測，2019-2024 年、2024-2029 年、2034 年
• 醫院
• 學術研究機構
• 製藥和生物技術公司
• 血液成分供應商
• 血液中心
• 全球白血球分離設備市場：依治療性分離術細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 白血病治療系統
• 敗血症治療白血球分離術科
• 自體免疫疾病管理設備
• 全球白血球分離設備市場：依血球去除療法（類型）細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 血小板成分採集裝置
• 淋巴單採單元
• 紅血球成分分析系統
• 全球白血球分離設備市場：依幹細胞採集類型細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
• 周邊血幹細胞（PBSC）採集裝置
• 臍帶血採集系統
• 骨髓幹細胞單採系統
• 全球白血球分離設備市場：按應用（類型）細分、性能和預測，2019-2024 年、2024-2029 年、2034 年
• 用於研發的細胞分離系統
• 臨床試驗血液分離平台
• 學術實驗室白血球分離裝置
• 全球白血球分離設備市場：按白血球分離柱和細胞分離器（按類型）細分，實際和預測，2019-2024 年、2024-2029 年、2034 年
• 吸附柱
• 基於膜的細胞分離系統
• 離心細胞分離器
• 全球白血球分離設備市場：細分：白血球分離一次性用品（按類型）、實際及預測，2019-2024 年、2024-2029 年、2034 年
• 管組
• 針頭和導管
• 收集袋
• 全球白血球分離設備市場：按分離設備類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
• 常規流式血液分離裝置
• 可攜式或移動式血液分離裝置
• 間歇流血液分離系統

第7章 區域和國家分析

• 全球白血球分離設備市場：區域表現及預測（2019-2024 年、2024-2029 年及 2034 年）
• 全球白血球分離設備市場：依國家/地區、績效及預測（2019-2024 年、2024-2029 年及 2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

• 白血球分離設備市場：競爭格局
• 白血球分離設備市場：公司簡介
  • Fresenius SE and Co. KGaA Overview, Products and Services, Strategy and Financial Analysis
  • Asahi Kasei Medical Co. Ltd Overview, Products and Services, Strategy and Financial Analysis
  • Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Grifols SA Overview, Products and Services, Strategy and Financial Analysis
  • TERUMO BCT INC. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

• Kaneka Corporation
• Charles River Laboratories International Inc.
• Mallinckrodt Pharmaceuticals
• Nikkiso Co. Ltd.
• Haemonetics Corporation
• Miltenyi Biotec GmbH
• Macopharma
• Precision for Medicine Inc.
• B. Braun Melsungen AG
• BioIVT LLC
• AllCells LLC
• Kawasumi Laboratories Inc.
• Beijing Zksk Technology Co. Ltd.
• Puriblood Medical Co. Ltd
• Medica SpA

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

• 2029 年白血球分離設備市場：提供新機會的國家
• 2029 年白血球分離設備市場：細分市場帶來新機會
• 2029 年白血球分離設備市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手策略

第36章 附錄

A leukapheresis device is a specialized medical tool designed to selectively isolate and collect white blood cells (leukocytes) from the blood of a patient or donor through centrifugation or filtration methods. It serves an essential function in therapies such as leukemia treatment, stem cell transplantation, and autoimmune disorder management, and is also utilized in clinical research and diagnostic procedures.

The primary categories of leukapheresis devices include therapeutic leukapheresis, cytapheresis, stem cell collection, research applications, leukapheresis columns and cell separators, leukapheresis disposables, and apheresis devices. Therapeutic leukapheresis is a medical technique employed to extract surplus or abnormal white blood cells from the bloodstream, aiming to alleviate symptoms or avoid related complications. These systems comprise various elements, including leukapheresis machines, blood collection sets, medical consumables, and filtration components. The diverse group of end users includes hospitals, academic and research organizations, pharmaceutical and biotechnology firms, blood centers, and providers of blood components.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The leukapheresis device market research report is one of a series of new reports from The Business Research Company that provides leukapheresis device market statistics, including the leukapheresis device industry's global market size, regional shares, competitors with the leukapheresis device market share, detailed leukapheresis device market segments, market trends and opportunities, and any further data you may need to thrive in the leukapheresis device market. This leukapheresis device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The leukapheresis device market size has grown strongly in recent years. It will grow from $0.65 billion in 2024 to $0.70 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth during the historical period can be credited to the rising demand for personalized medicine, enhanced emphasis on research and development, an increasing number of clinical trials, a growing elderly population, and the expanding adoption of minimally invasive procedures.

The leukapheresis device market size is expected to see strong growth in the next few years. It will grow to $0.94 billion in 2029 at a compound annual growth rate (CAGR) of 7.5%. The growth projected for the forecast period can be attributed to the rising prevalence of blood-related disorders, increasing incidence of cancer, growing demand for peripheral blood stem cell collection, expanding use of leukapheresis in cellular therapies, and heightened investments in regenerative medicine and immunotherapy. Major trends anticipated during this period include technological innovations in apheresis devices, integration of automation and digital technologies, progress in point-of-care leukapheresis systems, advancements in closed-loop leukapheresis technologies, and technology-enhanced improvements in cell separation efficiency.

The increasing prevalence of blood-related disorders is anticipated to drive the growth of the leukapheresis device market. These disorders affect the structure or function of blood cells, leading to complications with oxygen transport, immune function, and blood clotting. One of the primary reasons for this rise is the aging population, which is more prone to developing conditions such as anemia, leukemia, and other hematologic diseases. Leukapheresis devices play a crucial role in managing these conditions by selectively removing excess or abnormal white blood cells from the bloodstream, thereby easing symptoms and lowering the risk of complications in illnesses like leukemia and autoimmune disorders. For example, in May 2024, the Leukaemia Foundation, an Australian non-profit organization, reported that in 2022, approximately 19,403 Australians were diagnosed with blood cancers, including leukemia, lymphoma, and myeloma. This equates to around 53 new cases each day, or one diagnosis every 27 minutes. Presently, nearly 135,000 Australians are living with a blood cancer or disorder, and projections indicate this number could exceed 275,000 by 2035. This upward trend in blood-related conditions is contributing significantly to the growing demand for leukapheresis devices.

Key players in the leukapheresis device market are increasingly investing in regional production capabilities to improve access to therapeutic devices and align with national healthcare strategies. Establishing local manufacturing facilities helps to streamline supply chains, reduce reliance on imports, and enhance the affordability and availability of advanced blood and cell collection systems. For instance, in November 2024, Terumo Blood and Cell Technologies, a US-based medical technology firm, collaborated with its China-based subsidiary, Terumo Medical Products (Hangzhou) Co., Ltd., to initiate localized production in Hangzhou. This initiative focuses on producing vital leukapheresis products, such as the Trima Accel Automated Blood Collection System and the Spectra Optia Apheresis System, which are widely used in China for procedures including therapeutic apheresis, stem cell collection, and blood component separation.

In July 2022, Discovery Life Sciences, a US-based provider of highly characterized human biospecimens, completed the acquisition of AllCells LLC for an undisclosed sum. The acquisition is intended to create a comprehensive, scalable solution offering clients consistent access to high-quality human cellular starting materials along with integrated analytical services to support the development of cell and gene therapies. AllCells LLC, also based in the US, is a biotechnology company that specializes in leukapheresis devices for the targeted collection of blood cells.

Major players in the leukapheresis device market are Fresenius SE and Co. KGaA, Asahi Kasei Medical Co. Ltd, Baxter International Inc., Grifols S.A., TERUMO BCT INC., Kaneka Corporation, Charles River Laboratories International Inc., Mallinckrodt Pharmaceuticals, Nikkiso Co. Ltd., Haemonetics Corporation, Miltenyi Biotec GmbH, Macopharma, Precision for Medicine Inc., B. Braun Melsungen AG, BioIVT LLC, AllCells LLC, Kawasumi Laboratories Inc., Beijing Zksk Technology Co. Ltd., Puriblood Medical Co. Ltd, and Medica S.p.A.

North America was the largest region in the leukapheresis device market in 2024. The regions covered in leukapheresis device report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the leukapheresis device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The leukapheresis device market consists of sales of leukapheresis software and monitoring systems, blood flow controllers and pumps, and centrifuge rotors and tubing sets. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Leukapheresis Device Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on leukapheresis device market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for leukapheresis device ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The leukapheresis device market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Device Type: Therapeutic Leukapheresis; Cytapheresis; Stem Cell Collection; Research Applications; Leukapheresis Columns and Cell Separators; Leukapheresis Disposables; Apheresis Devices
• 2) By Component: Leukapheresis Machine; Blood Collection Set ; Medical Consumables ; Filters
• 3) By End User: Hospitals; Academic Research Institutes; Pharmaceutical And Biotechnology Companies; Blood Component Providers; Blood Centers
• Subsegments:
• 1) By Therapeutic Leukapheresis: Leukemia Treatment Systems; Sepsis Treatment Leukapheresis Units; Autoimmune Disease Management Devices
• 2) By Cytapheresis: Plateletpheresis Devices; Lymphapheresis Units; Erythrocytapheresis Systems
• 3) By Stem Cell Collection: Peripheral Blood Stem Cell (PBSC) Collection Devices; Umbilical Cord Blood Collection Systems; Bone Marrow Stem Cell Apheresis Systems
• 4) By Research Applications: Cell Separation Systems for Research and Development; Clinical Trial Apheresis Platforms; Academic Laboratory Leukapheresis Devices
• 5) By Leukapheresis Columns And Cell Separators: Adsorption Columns; Membrane-Based Cell Separation Systems; Centrifugal Cell Separators
• 6) By Leukapheresis Disposables: Tubing Sets; Needles And Catheters; Collection Bags
• 7) By Apheresis Devices: Continuous Flow Apheresis Machines; Portable Or Mobile Apheresis Units; Intermittent Flow Apheresis Systems
• Companies Mentioned: Fresenius SE and Co. KGaA; Asahi Kasei Medical Co. Ltd; Baxter International Inc.; Grifols S.A.; TERUMO BCT INC.; Kaneka Corporation; Charles River Laboratories International Inc.; Mallinckrodt Pharmaceuticals; Nikkiso Co. Ltd.; Haemonetics Corporation; Miltenyi Biotec GmbH; Macopharma; Precision for Medicine Inc.; B. Braun Melsungen AG; BioIVT LLC; AllCells LLC; Kawasumi Laboratories Inc.; Beijing Zksk Technology Co. Ltd.; Puriblood Medical Co. Ltd; Medica S.p.A.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Leukapheresis Device Market Characteristics

3. Leukapheresis Device Market Trends And Strategies

4. Leukapheresis Device Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Leukapheresis Device Growth Analysis And Strategic Analysis Framework

• 5.1. Global Leukapheresis Device PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Leukapheresis Device Market Growth Rate Analysis
• 5.4. Global Leukapheresis Device Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Leukapheresis Device Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Leukapheresis Device Total Addressable Market (TAM)

6. Leukapheresis Device Market Segmentation

• 6.1. Global Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Therapeutic Leukapheresis
• Cytapheresis
• Stem Cell Collection
• Research Applications
• Leukapheresis Columns and Cell Separators
• Leukapheresis Disposables
• Apheresis Devices
• 6.2. Global Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Leukapheresis Machine
• Blood Collection Set
• Medical Consumables
• Filters
• 6.3. Global Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Academic Research Institutes
• Pharmaceutical And Biotechnology Companies
• Blood Component Providers
• Blood Centers
• 6.4. Global Leukapheresis Device Market, Sub-Segmentation Of Therapeutic Leukapheresis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Leukemia Treatment Systems
• Sepsis Treatment Leukapheresis Units
• Autoimmune Disease Management Devices
• 6.5. Global Leukapheresis Device Market, Sub-Segmentation Of Cytapheresis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Plateletpheresis Devices
• Lymphapheresis Units
• Erythrocytapheresis Systems
• 6.6. Global Leukapheresis Device Market, Sub-Segmentation Of Stem Cell Collection, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Peripheral Blood Stem Cell (Pbsc) Collection Devices
• Umbilical Cord Blood Collection Systems
• Bone Marrow Stem Cell Apheresis Systems
• 6.7. Global Leukapheresis Device Market, Sub-Segmentation Of Research Applications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cell Separation Systems For Research And Development
• Clinical Trial Apheresis Platforms
• Academic Laboratory Leukapheresis Devices
• 6.8. Global Leukapheresis Device Market, Sub-Segmentation Of Leukapheresis Columns And Cell Separators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Adsorption Columns
• Membrane-Based Cell Separation Systems
• Centrifugal Cell Separators
• 6.9. Global Leukapheresis Device Market, Sub-Segmentation Of Leukapheresis Disposables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tubing Sets
• Needles And Catheters
• Collection Bags
• 6.10. Global Leukapheresis Device Market, Sub-Segmentation Of Apheresis Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Continuous Flow Apheresis Machines
• Portable Or Mobile Apheresis Units
• Intermittent Flow Apheresis Systems

7. Leukapheresis Device Market Regional And Country Analysis

• 7.1. Global Leukapheresis Device Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Leukapheresis Device Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Leukapheresis Device Market

• 8.1. Asia-Pacific Leukapheresis Device Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Leukapheresis Device Market

• 9.1. China Leukapheresis Device Market Overview
• 9.2. China Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Leukapheresis Device Market

• 10.1. India Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Leukapheresis Device Market

• 11.1. Japan Leukapheresis Device Market Overview
• 11.2. Japan Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Leukapheresis Device Market

• 12.1. Australia Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Leukapheresis Device Market

• 13.1. Indonesia Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Leukapheresis Device Market

• 14.1. South Korea Leukapheresis Device Market Overview
• 14.2. South Korea Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Leukapheresis Device Market

• 15.1. Western Europe Leukapheresis Device Market Overview
• 15.2. Western Europe Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Leukapheresis Device Market

• 16.1. UK Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Leukapheresis Device Market

• 17.1. Germany Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Leukapheresis Device Market

• 18.1. France Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Leukapheresis Device Market

• 19.1. Italy Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Leukapheresis Device Market

• 20.1. Spain Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Leukapheresis Device Market

• 21.1. Eastern Europe Leukapheresis Device Market Overview
• 21.2. Eastern Europe Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Leukapheresis Device Market

• 22.1. Russia Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Leukapheresis Device Market

• 23.1. North America Leukapheresis Device Market Overview
• 23.2. North America Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Leukapheresis Device Market

• 24.1. USA Leukapheresis Device Market Overview
• 24.2. USA Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Leukapheresis Device Market

• 25.1. Canada Leukapheresis Device Market Overview
• 25.2. Canada Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Leukapheresis Device Market

• 26.1. South America Leukapheresis Device Market Overview
• 26.2. South America Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Leukapheresis Device Market

• 27.1. Brazil Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Leukapheresis Device Market

• 28.1. Middle East Leukapheresis Device Market Overview
• 28.2. Middle East Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Leukapheresis Device Market

• 29.1. Africa Leukapheresis Device Market Overview
• 29.2. Africa Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Leukapheresis Device Market Competitive Landscape And Company Profiles

• 30.1. Leukapheresis Device Market Competitive Landscape
• 30.2. Leukapheresis Device Market Company Profiles
  • 30.2.1. Fresenius SE and Co. KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Asahi Kasei Medical Co. Ltd Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Grifols S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. TERUMO BCT INC. Overview, Products and Services, Strategy and Financial Analysis

31. Leukapheresis Device Market Other Major And Innovative Companies

• 31.1. Kaneka Corporation
• 31.2. Charles River Laboratories International Inc.
• 31.3. Mallinckrodt Pharmaceuticals
• 31.4. Nikkiso Co. Ltd.
• 31.5. Haemonetics Corporation
• 31.6. Miltenyi Biotec GmbH
• 31.7. Macopharma
• 31.8. Precision for Medicine Inc.
• 31.9. B. Braun Melsungen AG
• 31.10. BioIVT LLC
• 31.11. AllCells LLC
• 31.12. Kawasumi Laboratories Inc.
• 31.13. Beijing Zksk Technology Co. Ltd.
• 31.14. Puriblood Medical Co. Ltd
• 31.15. Medica S.p.A.

32. Global Leukapheresis Device Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Leukapheresis Device Market

34. Recent Developments In The Leukapheresis Device Market

35. Leukapheresis Device Market High Potential Countries, Segments and Strategies

• 35.1 Leukapheresis Device Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Leukapheresis Device Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Leukapheresis Device Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer